(0.58%) 5 157.43 points
(0.22%) 38 762 points
(0.62%) 16 256 points
(0.59%) $78.57
(3.64%) $2.22
(0.91%) $2 329.50
(2.91%) $27.47
(-0.10%) $964.35
(-0.12%) $0.928
(-0.41%) $10.83
(-0.22%) $0.795
(-0.10%) $91.36
3 days till quarter result
(bmo 2024-05-09)
Expected move: +/- 0.00%
-0.26% ¥ 1 166.00
Live Chart Being Loaded With Signals
WIN-Partners Co., Ltd., through its subsidiaries, distributes medical devices to medical institutions primarily in Japan. The company offers percutaneous transluminal coronary angioplasty balloon catheters, drug-eluting stents, and intravascular ultrasound catheters; pacemakers, implantable cardioverter defibrillators, cardiac resynchronization therapy defibrillators, and ablation catheters; and stent grafts, transcatheter heart valves, and mechanical heart valves...
Stats | |
---|---|
Dzisiejszy wolumen | 13 100.00 |
Średni wolumen | 50 229.00 |
Kapitalizacja rynkowa | 33.31B |
EPS | ¥0 ( 2024-02-06 ) |
Następna data zysków | ( ¥0 ) 2024-05-09 |
Last Dividend | ¥14.00 ( 2023-03-30 ) |
Next Dividend | ¥0 ( N/A ) |
P/E | 19.61 |
ATR14 | ¥0.890 (0.08%) |
WIN-Partners Co., Ltd. Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
WIN-Partners Co., Ltd. Finanse
Annual | 2022 |
Przychody: | ¥70.85B |
Zysk brutto: | ¥8.66B (12.23 %) |
EPS: | ¥72.04 |
FY | 2022 |
Przychody: | ¥70.85B |
Zysk brutto: | ¥8.66B (12.23 %) |
EPS: | ¥72.04 |
FY | 2022 |
Przychody: | ¥66.39B |
Zysk brutto: | ¥8.52B (12.83 %) |
EPS: | ¥63.88 |
FY | 2021 |
Przychody: | ¥62.12B |
Zysk brutto: | ¥7.74B (12.47 %) |
EPS: | ¥53.66 |
Financial Reports:
No articles found.
WIN-Partners Co., Ltd. Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
¥0 (N/A) |
¥0 (N/A) |
¥14.00 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | ¥12.50 | 2011-03-29 |
Last Dividend | ¥14.00 | 2023-03-30 |
Next Dividend | ¥0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 14 | -- |
Total Paid Out | ¥255.00 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.11 | -- |
Div. Sustainability Score | 5.79 | |
Div.Growth Potential Score | 3.99 | |
Div. Directional Score | 4.89 | -- |
Year | Amount | Yield |
---|
With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
4551.T | Ex Dividend Junior | 2023-12-28 | Semi-Annually | 0 | 0.00% | |
3778.T | Ex Dividend Knight | 2024-03-28 | Annually | 0 | 0.00% | |
3046.T | Ex Dividend Knight | 2023-08-30 | Annually | 0 | 0.00% | |
1928.T | Ex Dividend Knight | 2024-01-30 | Semi-Annually | 0 | 0.00% | |
9468.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% | |
8377.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% | |
7775.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
6941.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
6301.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
5020.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0228 | 1.500 | 9.54 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0381 | 1.200 | 8.73 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0758 | 1.500 | -0.268 | -0.403 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 1.905 | 0.800 | 5.48 | 4.38 | [1 - 3] |
quickRatioTTM | 1.697 | 0.800 | 4.72 | 3.78 | [0.8 - 2.5] |
cashRatioTTM | 0.825 | 1.500 | 6.53 | 9.79 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | 196 918 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 13.65 | 2.00 | 5.45 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 13.65 | 2.00 | 3.17 | 6.35 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.123 | 1.000 | -1.278 | -1.278 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0318 | 1.000 | -1.365 | -1.365 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 1.674 | 0.800 | 2.17 | 1.737 | [0.5 - 2] |
Total Score | 5.79 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 19.66 | 1.000 | 8.12 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0758 | 2.50 | -0.173 | -0.403 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 13.65 | 2.00 | 5.45 | 6.35 | [0 - 30] |
dividendYielPercentageTTM | 4.29 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 13.65 | 2.00 | 5.45 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 1.539 | 1.500 | 3.07 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.00524 | 1.000 | -2.37 | 0 | [0.1 - 0.5] |
Total Score | 3.99 |
WIN-Partners Co., Ltd.
WIN-Partners Co., Ltd., through its subsidiaries, distributes medical devices to medical institutions primarily in Japan. The company offers percutaneous transluminal coronary angioplasty balloon catheters, drug-eluting stents, and intravascular ultrasound catheters; pacemakers, implantable cardioverter defibrillators, cardiac resynchronization therapy defibrillators, and ablation catheters; and stent grafts, transcatheter heart valves, and mechanical heart valves. It also provides peripheral vascular stents, carotid artery stents, and embolic coils; and insulin pumps, as well as continuous glucose monitoring and magnetic resonance imaging equipment. The company was founded in 1973 and is headquartered in Tokyo, Japan.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej